Clinical trials
Phase 2 Neoplasm Metastasis trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Eli Lilly and Company | 1 |
| Incyte Corporation | 1 |
| Nektar Therapeutics | 1 |
| Tampere University Hospital | 1 |
| University of Turku | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 9 |
| Breast Neoplasms | 4 |
| Carcinoma, Transitional Cell | 2 |
| Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Acrocephalosyndactylia | 1 |
| Carcinoma, Renal Cell | 1 |
| Melanoma | 1 |
| Urologic Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.